These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22257579)

  • 1. Clinical and economic impact of a pharmacist-managed i.v.-to-p.o. conversion service for levofloxacin in Taiwan.
    Yen YH; Chen HY; Wuan-Jin L; Lin YM; Shen WC; Cheng KJ
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):136-41. PubMed ID: 22257579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral.
    Kuti JL; Le TN; Nightingale CH; Nicolau DP; Quintiliani R
    Am J Health Syst Pharm; 2002 Nov; 59(22):2209-15. PubMed ID: 12455304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
    File TM; Milkovich G; Tennenberg AM; Xiang JX; Khashab MM; Zadeikis N
    Curr Med Res Opin; 2004 Sep; 20(9):1473-81. PubMed ID: 15383197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study.
    Ho BP; Lau TT; Balen RM; Naumann TL; Jewesson PJ
    BMC Health Serv Res; 2005 Jun; 5():48. PubMed ID: 15987523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to drug therapy, formulary, and pathway management in a large community hospital.
    Halley HJ
    Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S17-21. PubMed ID: 11098316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.
    Clark LC; Davis CW
    Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S10-3. PubMed ID: 11098314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.
    Friedman H; Song X; Crespi S; Navaratnam P
    Value Health; 2009; 12(8):1135-43. PubMed ID: 19695010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a clinical pharmacy anemia management service on adherence to monitoring guidelines, clinical outcomes, and medication utilization.
    Debenito JM; Billups SJ; Tran TS; Price LC
    J Manag Care Spec Pharm; 2014 Jul; 20(7):715-20. PubMed ID: 24967524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist intervention in activated protein C therapy for severe sepsis: influence on health and economic outcomes.
    Chan AL; Hsieh HJ; Lin SJ
    Int J Clin Pharmacol Ther; 2009 Apr; 47(4):229-35. PubMed ID: 19356388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact and barriers of a pharmacist-led practice with computerized reminders on intravenous to oral antibiotic conversion for community-acquired pneumonia inpatients.
    Xu S; Wang X; Song Z; Han F; Zhang C
    J Clin Pharm Ther; 2021 Aug; 46(4):1055-1061. PubMed ID: 34101230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a physician order entry system to identify opportunities for intravenous to oral levofloxacin conversion.
    Glemaud I
    Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S14-6. PubMed ID: 11098315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist-managed intravenous to oral step-down program.
    Hunter KA; Dormaier GK
    Clin Ther; 1995; 17(3):534-40; discussion 516. PubMed ID: 7585857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital.
    Shen J; Sun Q; Zhou X; Wei Y; Qi Y; Zhu J; Yan T
    Int J Clin Pharm; 2011 Dec; 33(6):929-33. PubMed ID: 22068326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
    Dager WE; Branch JM; King JH; White RH; Quan RS; Musallam NA; Albertson TE
    Ann Pharmacother; 2000 May; 34(5):567-72. PubMed ID: 10852081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic impact of a pharmacist-intervention to promote sequential intravenous to oral clindamycin conversion.
    Martínez MJ; Freire A; Castro I; Inaraja MT; Ortega A; Del Campo V; Rodriguez I; Bardán B; Morano LE; Garcia JF
    Pharm World Sci; 2000 Apr; 22(2):53-8. PubMed ID: 10849923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations.
    Zhou Y; Ma LY; Zhao X; Tian SH; Sun LY; Cui YM
    J Clin Pharm Ther; 2015 Aug; 40(4):404-8. PubMed ID: 25913640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.
    Samsa GP; Matchar DB; Harnett J; Wilson J
    Chest; 2005 Nov; 128(5):3246-54. PubMed ID: 16304269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.